Eric A. Singer, MD, MA, FACS
Assistant Professor of Surgery, Director, Kidney Cancer Program, Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey, Director, Distinction in Bioethics Program, Rutgers Robert Wood Johnson Medical School, 195 Little Albany Street Room 4563, New Brunswick, NJ 08903, Canada
Dr Singer is a urologic surgeon with expertise in the management of genitourinary malignancies and a special interest in using robotic and minimally invasive surgery to treat cancers of the kidney, prostate, bladder and adrenal glands. His goal is to educate and empower my patients so that they can choose the best treatment option available, whether it is surgery, active surveillance, radiation, systemic therapy, or a clinical trial. To that end, he works closely with his Medical Oncology and Radiation Oncology colleagues in order to offer patients an effective, individualized, and comprehensive cancer treatment plan that minimizes side effects and maximizes quality-of-life.
Dr Singer joined the faculty of the Rutgers Cancer Institute of New Jersey in 2012 after completing a clinical and research fellowship in the Urologic Oncology Branch of the National Cancer Institute (NCI). He received his medical degree (MD) with Honors in Research from Georgetown University along with a master’s degree (MA) in bioethics. He performed his general surgery and urologic surgery training at the University of Rochester Medical Center where he also did a fellowship in clinical ethics. He has completed certificates in Clinical Research from the National Institutes of Health and the Harvard TH Chan School of Public Health.At the Rutgers Cancer Institute of New Jersey, Dr Singer is Director of the Kidney Cancer Program within the Section of Urologic Oncology. He is also a member of the Prostate Cancer Program, Clinical Investigations & Precision Therapeutics Program, Center for Minimally Invasive Surgery, and the Center for Biomedical Imaging & Informatics. His research is focused on the development of new treatments for patients with genitourinary malignancies through clinical trials. He is involved with both cooperative group and investigator-initiated trials. At the Rutgers Robert Wood Johnson Medical School, Dr Singer is an Assistant Professor of Surgery within the Division of Urology and Director of the Distinction in Bioethics Program.